Compare Lam Research Corporation (LRCX) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lam Research Corporation vs Novavax Inc — how do they compare? Lam Research Corporation trades at $321.51 (market cap $383.63B), while Novavax Inc trades at $7.9 (market cap $1.30B). The key difference: Lam Research Corporation is far larger — about 295.1× Novavax Inc's market cap, and Lam Research Corporation pays a 0.34% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| LRCX | NVAX | |
|---|---|---|
Market Cap | $383.63B | $1.30B |
Sector | Technology | Health |
52-Week High | $433.33 | $11.19 |
52-Week Low | $94.84 | $6.22 |
Enterprise Value | $382.61B | $800.50M |
Dividend Yield | 0.34% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
